Evaluating the Impact of Chitosan BMG™ Dressing on Malignant Fungating Wounds in Community Care

Publication Details:

Varnam, K. & Jackson, E. (2025) Evaluating the impact of chitosan BMG™ dressing on the management of malignant fungating wounds in community care: Physical and psychosocial outcomes. Wound Care Today, 2025

Wound Details

Two female patients with non-healing malignant fungating wounds (MFW) to the breast, static despite standard care:

  • Patient 1 (92 yrs): Anxiety and distress from bleeding and malodorous exudate inhibited family visits.
  • Patient 2 (72 yrs): Daily bleeding at dressing changes limited independence and required nurse-led changes.

Key Findings and Data:

Patient 1:

Baseline

  • Frequent minor bleeding
  • Pain 5 /10
  • Moderate–high malodour

After 4 Weeks of MaxioCel BMG™

  • Haemostasis achieved
  • Pain reduced to 3 /10
  • Malodour markedly decreased, restoring confidence for visits

Patient 2:

Baseline

  • Daily bleeding
  • Pain 6 /10

After 4 Weeks of MaxioCel BMG™

  • Bleeding controlled
  • Pain reduced to 0 within 7 days
  • Conformed to irregular bed, enabling self-care and daily showering

Evaluating the Impact of Chitosan BMG

Effect on Wound Bed and Management:

  • Debridement: The bioactive microfibre gelling action efficiently lifted slough/necrosis, exposing a clean wound bed.
  • Haemostasis & Exudate Control: Inherent chitosan haemostatics controlled bleeding; exudate and odour were significantly reduced, improving local conditions.

Clinician and Patient Feedback:

  • Clinicians: Reported MaxioCel BMG™ as reliable, easy to apply/remove atraumatically, and confidence-boosting in complex MFW management.
  • Patients:

Patient 1 felt “relieved and more at ease” welcoming family visits again

Screenshot 2025-06-12 234423

Patient 2 was “overwhelmed with happiness” at regaining autonomy and hygiene routines.

Screenshot 2025-06-12 234524

Key Insights:

Evaluating the Impact of Chitosan BMG
  • Rapid pain and odour reduction alongside bleeding control make MaxioCel BMG™ an effective symptom-management dressing for MFW.
  • Its ease of use and support for self-care empower patients and reduce community nursing workload.

Related Publications

Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers

Chronic Wound Debridement in an Acute Setting

Severe Pressure Ulcer Debridement in the Acute Sector

A Multi-disciplinary Team Approach to the Management